Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA

Melissa S. Nolan; David Aguilar; Arunima Misra; Sarah M. Gunter; Tim Erickson; Rodion Viktorovich Gorchakov; Hilda Rivera; Susan P. Montgomery; Kristy O. Murray

doi:10.3201/eid2707.203244

Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA

Melissa S. Nolan, David Aguilar, Arunima Misra, Sarah M. Gunter, Tim Erickson, Rodion Viktorovich Gorchakov, Hilda Rivera, Susan P. Montgomery, Kristy O. Murray

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefit from laboratory screening for T. cruzi infection.

Original language	English (US)
Pages (from-to)	1958-1960
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	27
Issue number	7
DOIs	https://doi.org/10.3201/eid2707.203244
State	Published - 2021

ASJC Scopus subject areas

Infectious Diseases
Epidemiology
Microbiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3201/eid2707.203244

https://repository.kaust.edu.sa/bitstream/10754/670230/1/Chagas_NICM_manuscript_12_15_20.pdf

Cite this

@article{ed3456f1898c462b95723918dbd28700,

title = "Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA",

abstract = "To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefit from laboratory screening for T. cruzi infection.",

author = "Nolan, {Melissa S.} and David Aguilar and Arunima Misra and Gunter, {Sarah M.} and Tim Erickson and Gorchakov, {Rodion Viktorovich} and Hilda Rivera and Montgomery, {Susan P.} and Murray, {Kristy O.}",

note = "KAUST Repository Item: Exported on 2021-07-16 Acknowledgements: We thank Kaila Fagerstrom for assisting with patient recruitment. This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant no. R21 AI114877-01).",

year = "2021",

doi = "10.3201/eid2707.203244",

language = "English (US)",

volume = "27",

pages = "1958--1960",

journal = "Emerging Infectious Diseases",

issn = "1080-6059",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "7",

}

TY - JOUR

T1 - Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA

AU - Nolan, Melissa S.

AU - Aguilar, David

AU - Misra, Arunima

AU - Gunter, Sarah M.

AU - Erickson, Tim

AU - Gorchakov, Rodion Viktorovich

AU - Rivera, Hilda

AU - Montgomery, Susan P.

AU - Murray, Kristy O.

N1 - KAUST Repository Item: Exported on 2021-07-16 Acknowledgements: We thank Kaila Fagerstrom for assisting with patient recruitment. This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant no. R21 AI114877-01).

PY - 2021

Y1 - 2021

N2 - To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefit from laboratory screening for T. cruzi infection.

AB - To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefit from laboratory screening for T. cruzi infection.

UR - http://hdl.handle.net/10754/670230

UR - https://wwwnc.cdc.gov/eid/article/27/7/20-3244_article.htm

U2 - 10.3201/eid2707.203244

DO - 10.3201/eid2707.203244

M3 - Article

C2 - 34152952

SN - 1080-6059

VL - 27

SP - 1958

EP - 1960

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 7

ER -

Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this